The overall goal of the Pluripotent Stem Cell and Organoid Core of the Digestive Health Center (DHC) is to provide new, cutting edge technologies that are focused on digestive disease research and enable the use of tissue organoids to model human disease. The Core pursues this goal with four complementary aims. In the first aim ?to provide DHC investigators with quality tested PSCs and PSC-derived GI tissues,? the Core makes available to users quality-tested human pluripotent stem cells (PSCs) and PSC-derived intestinal and gastric organoids. These are novel 3D-miniature organs that enable studies related to physiology and pathobiology relevant to humans. In the second aim ?to generate biopsy-derived human enteroids for DHC investigators,? the Core also provides investigators with the opportunity to generate gastric, intestinal, and colonic ?enteroids? from healthy or diseased subjects. In the third aim ?to derive and quality test disease-specific induced PSC,? the Core applies well-established transfection, culture, and phenotyping protocols to generate inducible PSCs (iPSCs) from normal and diseased subjects to facilitate studies of pathogenesis of disease, drug screening, etc. To be able to track and visualize these cells in experimental assays, the Core also provide PSC-editing and screening services to establish novel cell lines based on investigators' needs. And in the fourth aim ?to sponsor training courses and workshops on PSC and organoid technology,? the Core holds regular sessions on basic and advanced techniques for PSC culture, generation of iPSCs, and generation and use of human digestive tissue organoids. These novel technologies empower DHC investigators to study mechanisms of disease using multi-cellular experimental systems that have direct ?lineage? to normal and diseased human tissues (including at different stages of maturation). The delivery of services is streamlined and centralized, and positions investigators to explore new collaborative projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK078392-13
Application #
9710666
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
13
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Schwartz, Justin T; Morris, David W; Collins, Margaret H et al. (2018) Eosinophil progenitor levels correlate with tissue pathology in pediatric eosinophilic esophagitis. J Allergy Clin Immunol :
Denson, Lee A; Jurickova, Ingrid; Karns, Rebekah et al. (2018) Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease. Gastroenterology 154:2097-2110
Engevik, Kristen A; Matthis, Andrea L; Montrose, Marshall H et al. (2018) Organoids as a Model to Study Infectious Disease. Methods Mol Biol 1734:71-81
Poling, Holly M; Wu, David; Brown, Nicole et al. (2018) Mechanically induced development and maturation of human intestinal organoids in vivo. Nat Biomed Eng 2:429-442
Rydyznski, Carolyn E; Cranert, Stacey A; Zhou, Julian Q et al. (2018) Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers. Cell Rep 24:3367-3373.e4
Azouz, Nurit P; Ynga-Durand, Mario A; Caldwell, Julie M et al. (2018) The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses. Sci Transl Med 10:
Kimura, Masaki; Azuma, Momoko; Zhang, Ran-Ran et al. (2018) Digitalized Human Organoid for Wireless Phenotyping. iScience 4:294-301
Mahe, Maxime M (2018) Engineering a second brain in a dish. Brain Res 1693:165-168
Valanejad, Leila; Cast, Ashley; Wright, Mary et al. (2018) PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma. Commun Biol 1:67
Taylor, Amy E; Carey, Alexandra N; Kudira, Ramesh et al. (2018) Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing Cholangitis. Hepatology 68:1905-1921

Showing the most recent 10 out of 543 publications